Vera Therapeutics, Inc.
NASDAQ:VERA
23.37 (USD) • At close April 30, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 92.646 | 45.681 | 114.653 | 79.674 | 53.654 | 3.195 |
| Short Term Investments
| 548.206 | 115.035 | 71.194 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 640.852 | 160.716 | 114.653 | 79.674 | 53.654 | 3.195 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0.052 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0.472 | 0 |
| Other Current Assets
| 0.913 | 11.307 | 11.045 | 2.863 | 0.505 | 0.37 |
| Total Current Assets
| 651.218 | 172.023 | 125.698 | 82.537 | 54.261 | 3.565 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 4.332 | 3.041 | 5.173 | 0 | 0 | 1.394 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0.011 | 0.058 | 0.867 | 0.293 | 0.363 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.131 | 0.471 | 0.506 | 0.344 | 0 | 0.059 |
| Total Non-Current Assets
| 4.463 | 3.523 | 5.737 | 1.211 | 0.293 | 1.816 |
| Total Assets
| 655.681 | 175.546 | 131.435 | 83.748 | 54.554 | 5.381 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 7.665 | 11.118 | 11.991 | 1.385 | 0.909 | 0.342 |
| Short Term Debt
| 1.483 | 2.436 | 5.29 | 0 | 0 | 0.122 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0.533 | 0.376 |
| Other Current Liabilities
| 16.223 | 8.749 | 8.319 | 6.305 | 1.497 | 0.596 |
| Total Current Liabilities
| 25.371 | 22.303 | 25.6 | 7.69 | 2.406 | 1.06 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 50.687 | 51.272 | 28.641 | 4.923 | 0 | 0.01 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 2.468 | 0.286 | 0.286 | 1.543 | 141.496 | 40.859 |
| Total Non-Current Liabilities
| 53.155 | 51.558 | 28.927 | 6.466 | 141.496 | 40.869 |
| Total Liabilities
| 78.526 | 73.861 | 54.527 | 14.156 | 143.902 | 41.929 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 83.748 | 139.576 | 40.095 |
| Common Stock
| 0.064 | 0.044 | 0.028 | 0.021 | 0.004 | 0.004 |
| Retained Earnings
| -461.25 | -309.102 | -213.112 | -124.056 | -91.447 | -38.034 |
| Accumulated Other Comprehensive Income/Loss
| 0.393 | 0.251 | -0.224 | -83.748 | -139.58 | -40.099 |
| Other Total Stockholders Equity
| 1,037.948 | 410.492 | 290.216 | 277.375 | 2.103 | 1.49 |
| Total Shareholders Equity
| 577.155 | 101.685 | 76.908 | 69.592 | -89.348 | -36.548 |
| Total Equity
| 577.155 | 101.685 | 76.908 | 69.592 | -89.348 | -36.548 |
| Total Liabilities & Shareholders Equity
| 655.681 | 175.546 | 131.435 | 83.748 | 54.554 | 5.381 |